Caliper Life Sciences Buyout for $10.50 Per Share Prompts Securities Lawyers at Goldfarb Branham Law Firm LLP to Investigate Potential Shareholder Claims
DALLAS, Sept. 19, 2011 /PRNewswire/ -- Securities lawyers at Goldfarb Branham LLP are investigating whether board of directors of Caliper Life Sciences (NASDAQ: CALP) violated shareholder protection laws in its proposed buyout by PerkinElmer, Inc. (NASDAQ: PKI) for $10.50 per share. Concerned investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or [email protected] about their rights and remedies.
"The offer represents a premium of 42% for CALP shareholders, but the company reported on September 7, 2011 that it has $34 million as a result of organic growth, which is up 24% for the first half of the year. The buyout will result in a cash out for shareholders while CEO Robert F. Friel remains with the company," securities lawyer Hamilton Lindley said. "Our proposed class action lawsuit seeks to ensure that the investors received reasonable value and information in this buyout."
Goldfarb Branham LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. CALP investors – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at
[email protected] or 877-583-2855.
Hamilton Lindley
Goldfarb Branham LLP
2501 N. Harwood, Ste. 1801
Dallas, TX 75201
(877) 583-2855 Toll Free Telephone
(214) 583-2233 Local Phone Number
(214) 583-2234 Fax Number
[email protected]
www.goldfarbbranham.com
SOURCE Goldfarb Branham LLP
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article